QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO., LTD. Financials Qinghai Spring Medicinal Resources Technology Co., Ltd.
Equities
600381
CNE0000017W0
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.29 CNY | +0.70% |
|
+0.94% | -44.50% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6,692 | 3,376 | 3,164 | 5,055 | 4,949 | 7,227 |
| Enterprise Value (EV) 1 | 5,475 | 2,442 | 2,826 | 4,842 | 4,750 | 7,062 |
| P/E ratio | 21.7 x | 47.8 x | 539 x | -15.9 x | -20.1 x | -25.1 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 14.2 x | 10.1 x | 13.5 x | 40.7 x | 38.7 x | 45.1 x |
| EV / Revenue | 11.6 x | 7.33 x | 12.1 x | 39 x | 37.2 x | 44.1 x |
| EV / EBITDA | 28.4 x | -185 x | -150 x | -48.4 x | -28 x | -42 x |
| EV / FCF | 114 x | -13.6 x | 12.6 x | -20.1 x | -56.7 x | 127 x |
| FCF Yield | 0.87% | -7.36% | 7.91% | -4.98% | -1.76% | 0.79% |
| Price to Book | 2.9 x | 1.42 x | 1.32 x | 2.44 x | 2.72 x | 4.71 x |
| Nbr of stocks (in thousands) | 630,754 | 588,075 | 587,061 | 587,061 | 587,061 | 587,061 |
| Reference price 2 | 10.61 | 5.740 | 5.390 | 8.610 | 8.430 | 12.31 |
| Announcement Date | 4/15/18 | 4/18/19 | 4/29/20 | 4/29/21 | 4/25/22 | 4/28/23 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 471.1 | 333 | 233.7 | 124.3 | 127.8 | 160.2 |
| EBITDA 1 | 192.5 | -13.22 | -18.81 | -100 | -169.7 | -168.2 |
| EBIT 1 | 150 | -54.04 | -57.48 | -139.7 | -209.9 | -207.7 |
| Operating Margin | 31.83% | -16.23% | -24.59% | -112.43% | -164.28% | -129.7% |
| Earnings before Tax (EBT) 1 | 344.2 | 63.65 | -1.722 | -315 | -252.5 | -295.3 |
| Net income 1 | 311.7 | 68.45 | 5.808 | -319.5 | -248.6 | -287.5 |
| Net margin | 66.16% | 20.55% | 2.48% | -257.14% | -194.59% | -179.52% |
| EPS 2 | 0.4900 | 0.1200 | 0.0100 | -0.5400 | -0.4200 | -0.4900 |
| Free Cash Flow 1 | 47.88 | -179.7 | 223.5 | -241.1 | -83.72 | 55.74 |
| FCF margin | 10.16% | -53.96% | 95.6% | -194.04% | -65.53% | 34.8% |
| FCF Conversion (EBITDA) | 24.88% | - | - | - | - | - |
| FCF Conversion (Net income) | 15.36% | - | 3,847.49% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/15/18 | 4/18/19 | 4/29/20 | 4/29/21 | 4/25/22 | 4/28/23 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 1,217 | 933 | 338 | 213 | 198 | 164 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 47.9 | -180 | 223 | -241 | -83.7 | 55.7 |
| ROE (net income / shareholders' equity) | 14.5% | 2.92% | 0.24% | -14.3% | -12.8% | -17.1% |
| ROA (Net income/ Total Assets) | 4.04% | -1.39% | -1.48% | -3.78% | -6.47% | -7.62% |
| Assets 1 | 7,716 | -4,934 | -391.6 | 8,444 | 3,842 | 3,773 |
| Book Value Per Share 2 | 3.660 | 4.050 | 4.070 | 3.520 | 3.100 | 2.610 |
| Cash Flow per Share 2 | 0.3300 | 0.5300 | 0.4700 | 0.3100 | 0.2800 | 0.2900 |
| Capex 1 | 20.7 | 43.5 | 5.29 | 198 | 122 | 0.82 |
| Capex / Sales | 4.4% | 13.07% | 2.26% | 159.04% | 95.33% | 0.51% |
| Announcement Date | 4/15/18 | 4/18/19 | 4/29/20 | 4/29/21 | 4/25/22 | 4/28/23 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -44.50% | 348M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
- Stock Market
- Equities
- 600381 Stock
- Financials Qinghai Spring Medicinal Resources Technology Co., Ltd.
